Currently out of the existing stock ratings of Alex Arfaei, 34 are a HOLD (33.66%), 53 are a BUY (52.48%), 14 are a SELL (13.86%).

Alex Arfaei

Work Performance Price Targets & Ratings Chart

Analyst Alex Arfaei works with a stock forecast success ratio of 100% fulfilled within 534 days on average. Previously, Alex Arfaei worked at BMO.

Alex Arfaei’s has documented 186 price targets and ratings displayed on 8 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on ZTS, Zoetis at 09-May-2019.

Wall Street Analyst Alex Arfaei

Analyst best performing recommendations are on ABBV (ABBVIE).
The best stock recommendation documented was for ABBV (ABBVIE) at 5/23/2018. The price target of $78 was fulfilled within 2 days with a profit of $3.11 (3.83%) receiving and performance score of 19.17.

Average potential price target upside

ABBV AbbVie BMY Bristol-Myers Squibb Company LLY Eli Lilly and Company MRK Merck mpany PFE Pfizer AZN AstraZeneca PLC ADR KIN Kindred Biosciences ZTS Zoetis

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

195

$25.2 (14.84%)

185

17 days ago

10/12 (83.33%)

$14.65 (8.12%)

191

Buy

189

$19.2 (11.31%)

181

2 months 7 days ago

9/11 (81.82%)

$15.71 (9.07%)

252

Buy

195

$25.2 (14.84%)

180

2 months 7 days ago

9/10 (90%)

$21.71 (12.53%)

445

Hold

165

$-4.8 (-2.83%)

157

2 months 27 days ago

11/11 (100%)

$2.96 (1.83%)

314

Buy

180

$10.2 (6.01%)

195

3 months 10 days ago

3/5 (60%)

$21.06 (13.25%)

496

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Alex Arfaei?

On 2012

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?